Cargando…

Associations between Urinary Advanced Glycation End Products and Cardiometabolic Parameters in Metabolically Healthy Obese Women

Advanced glycation end products (AGEs) have been implicated in the pathophysiology of type 2 diabetes and cardiovascular disease. We aimed to determine the associations of urinary carboxymethyl-lysine (CML) and methylglyoxal-hydroimidazolone (MG-H1) levels with cardiometabolic parameters in metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baye, Estifanos, Mark, Alicja B, Poulsen, Malene W, Andersen, Jeanette M, Dragsted, Lars O, Bügel, Sussane G, de Courten, Barbora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678993/ https://www.ncbi.nlm.nih.gov/pubmed/31295874 http://dx.doi.org/10.3390/jcm8071008

Ejemplares similares

Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials
por: Baye, Estifanos, et al.
Publicado: (2017)

Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial
por: Baye, Estifanos, et al.
Publicado: (2018)

Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018)

Author Correction: Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial
por: Baye, Estifanos, et al.
Publicado: (2020)

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial
por: de Courten, Barbora, et al.
Publicado: (2015)

Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial
por: Menon, Kirthi, et al.
Publicado: (2021)

Urinary excretion of advanced glycation end products in dogs and cats
por: Palaseweenun, Pornsucha, et al.
Publicado: (2020)

Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection
por: El Kamari, Vanessa, et al.
Publicado: (2021)

Blood and Tissue Advanced Glycation End Products as Determinants of Cardiometabolic Disorders Focusing on Human Studies
por: Kim, Yoona
Publicado: (2023)

Muscle Carnosine Is Associated with Cardiometabolic Risk Factors in Humans
por: de Courten, Barbora, et al.
Publicado: (2015)

Husbands’ participation in birth preparedness and complication readiness plan in Kucha district, Gamo Zone, Southern Ethiopia
por: Gultie, Teklemariam, et al.
Publicado: (2021)

Increased Inflammation and Cardiometabolic Risk in Individuals with Low AMY1 Copy Numbers
por: Marquina, Clara, et al.
Publicado: (2019)

Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits
por: Zawada, Agnieszka, et al.
Publicado: (2022)

Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis
por: Nadali, Mitra, et al.
Publicado: (2021)

Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
por: Arivazhagan, Lakshmi, et al.
Publicado: (2022)

Chronic Spontaneous Urticaria Is Characterized by Lower Serum Advanced Glycation End-Products
por: Grzanka, Alicja, et al.
Publicado: (2014)

Glycated Serum Protein Genetics and Pleiotropy with Cardiometabolic Risk Factors
por: Johnson, Matthew P., et al.
Publicado: (2019)

The Association between the Level of Advanced Glycation End Products and Objective Skin Quality Parameters
por: Martinovic, Dinko, et al.
Publicado: (2023)

Vitamin D Vitamers Affect Vitamin D Status Differently in Young Healthy Males
por: Jakobsen, Jette, et al.
Publicado: (2017)

UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2020)

Ageing/Menopausal Status in Healthy Women and Ageing in Healthy Men Differently Affect Cardiometabolic Parameters
por: Campesi, Ilaria, et al.
Publicado: (2016)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
por: Naseri, Kaveh, et al.
Publicado: (2022)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Examination of the Effectiveness of the Healthy Empowered Active Lifestyles (HEAL) Program on Advanced Glycation End Products
por: Gregoski, Mathew J., et al.
Publicado: (2021)

A Prospective Analysis of Skin and Fingertip Advanced Glycation End-Product Devices in Healthy Volunteers
por: Adl Amini, Dominik, et al.
Publicado: (2022)

Meat and Human Health—Current Knowledge and Research Gaps
por: Geiker, Nina Rica Wium, et al.
Publicado: (2021)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
por: Liang, Libo, et al.
Publicado: (2018)

Data on advanced glycation end-products concentrations and haemodynamic parameters following caffeine and nicotine consumption in nursing students
por: Deltsidou, Anna, et al.
Publicado: (2020)

Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague–Dawley rats
por: Xu, Lei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o8i9fgcdj6rv0gdi842ehvp665